Executive Summary: VetPartners Australia, the EQT-owned veterinary group, has formally notified the ACCC of a proposal to acquire 100% of VetLove Holdings, the parent of 15 companion-animal clinics across South East Queensland and Northern New South Wales. The notification took effect on 9 October 2026 and is at Phase 1 initial assessment.
Key Facts
- Acquirer
- VetPartners Australia Pty Ltd, via newly incorporated Unity HoldCo Pty Ltd
- Target
- VetLove Holdings Pty Ltd, majority owner of 15 veterinary clinics
- Deal
- Proposed acquisition of 100% of issued share capital
- Regulator
- Australian Competition and Consumer Commission, case MN-75031, Phase 1 initial assessment
- Market context
- Pet market Australia — 15 clinics join a 202-clinic platform in veterinary services consolidation
- Notification date
- 9 October 2026
- Ownership
- VetPartners is indirectly and solely controlled by EQT Fund Management S.a r.l.
- Location
- South East Queensland and Northern New South Wales, Australia
- Source
- ACCC Acquisitions Register
What Happened
VetPartners Australia has lodged a formal acquisition notification with the Australian Competition and Consumer Commission (ACCC) covering its proposal to buy VetLove Holdings Pty Ltd outright. According to the ACCC register entry, case number MN-75031, the notification took effect on 9 October 2026 and sits at Phase 1 initial assessment. VetPartners, acting through a newly incorporated holding company named Unity HoldCo Pty Ltd, proposes to acquire 100% of the issued share capital in VetLove Holdings, which holds majority shareholdings in the group’s 15 veterinary clinics.
Background
VetPartners supplies general veterinary services to companion animals through a network of 202 clinics across Australia, including 51 in Queensland and 50 in New South Wales, per the ACCC notification. Beyond general practice, the group operates the Brisbane Veterinary Specialist Centre and other specialist and emergency hospitals, United Vets Group, a veterinary buying group, Pet Chemist, an online veterinary pharmacy, and Pet Angel, a pet crematorium. EQT Fund Management S.a r.l., which indirectly holds and solely controls VetPartners, also holds an interest in Dechra Pharmaceuticals, a global veterinary pharmaceuticals supplier. EQT acquired VetPartners from National Veterinary Associates in late 2023 in a deal reported at the time to be worth around A$1.4 billion.
Industry Context
Veterinary services have become one of the most actively consolidated corners of the pet market australia and New Zealand share, with private-equity-backed groups adding clinics while independent owners retire. VetLove operates 15 general practice clinics across South East Queensland and Northern New South Wales, a footprint that plugs directly into VetPartners’ existing Queensland and New South Wales density. The acquisition sits in the same pattern as Greencross, Apiam and CVS Group’s Australian expansions: corporate groups buying adjacent clinic clusters rather than greenfield builds.
Market & Business Impact
If cleared, the deal would lift VetPartners’ Australian network from 202 to roughly 217 clinics and deepen its share of general practice in the Brisbane-to-Gold Coast corridor and the Northern Rivers region. For suppliers, a larger VetPartners network means more purchasing routed through United Vets Group and the group’s own pharmacy channel, Pet Chemist. The ACCC’s Phase 1 assessment will decide whether the transaction raises concerns; at the time of writing the case remains under assessment and no competition concerns have been published.
Companies & Brands Involved
VetPartners Australia Pty Ltd is the acquirer and part of EQT’s healthcare portfolio. Unity HoldCo Pty Ltd is the newly incorporated acquisition vehicle. VetLove Holdings Pty Ltd is the target and parent of the 15-clinic VetLove group. EQT Fund Management S.a r.l. is the ultimate controller of VetPartners and also holds an interest in Dechra Pharmaceuticals. The ACCC is the reviewing regulator.
Data & Evidence
Verified figures from the ACCC Acquisitions Register entry dated 9 October 2026: case number MN-75031; acquisition of 100% of issued share capital in VetLove Holdings Pty Ltd; VetLove holds majority shareholdings in 15 veterinary clinics across South East Queensland and Northern New South Wales; VetPartners operates 202 clinics across Australia, including 51 in Queensland and 50 in New South Wales; ANZSIC classifications 6240 and 6970. The register does not disclose transaction value, and GPI has not seen a price.
What This Means for the Pet Industry
Consolidation in Australian veterinary services is now a pipeline, not a series of one-off deals. A regulator-filed, structurally detailed notification like this one gives the industry a rare exact look at how roll-up vehicles are assembled: new holdco, 100% equity, adjacent regional cluster. Expect more Phase 1 notifications of this size as the remaining independent clinics in Queensland and New South Wales are approached; the watch item is whether the ACCC starts testing local-market overlap rather than treating each 10-to-20-clinic bolt-on as trivial.
Key Takeaways
- VetPartners Australia, controlled by EQT, has notified the ACCC of a proposal to acquire 100% of VetLove Holdings, parent of 15 veterinary clinics in South East Queensland and Northern New South Wales.
- The ACCC notification, case MN-75031, took effect on 9 October 2026 and is at Phase 1 initial assessment.
- VetPartners already runs 202 Australian clinics plus specialist hospitals, a buying group, an online veterinary pharmacy and a pet crematorium.
- EQT, which solely controls VetPartners, also holds an interest in veterinary pharmaceuticals supplier Dechra.
- No transaction value has been disclosed, and the deal remains subject to ACCC assessment.
Frequently Asked Questions
What is being acquired?
VetPartners Australia, through Unity HoldCo Pty Ltd, proposes to acquire 100% of the issued share capital in VetLove Holdings Pty Ltd, which holds majority shareholdings in 15 veterinary clinics.
Who owns VetPartners?
EQT Fund Management S.a r.l. indirectly holds and solely controls VetPartners, according to the ACCC notification; EQT also holds an interest in Dechra Pharmaceuticals.
Where are the VetLove clinics?
Across South East Queensland and Northern New South Wales, Australia.
Has the deal been cleared?
No. The ACCC lists the acquisition as under assessment at Phase 1 initial review, with the notification effective 9 October 2026.
Why does this matter for the pet industry?
Veterinary clinic consolidation shapes where pet owners can access care, how purchasing is aggregated, and how quickly corporate groups scale in the Australian market.
Sources
- Primary – Australian Competition and Consumer Commission, Acquisitions Register: VetPartners – VetLove Acquisition (MN-75031), https://accc.gov.au/public-registers/acquisitions-and-mergers-registers/acquisitions-register, 9 Oct 2026
